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 Due to increasing age, elderly are prone to non-communicable diseases 
(NCD), such as hypertension (HT) and diabetes mellitus (DM).  
Blood pressure (BP) and blood glucose level (BGL) are vital to be 
monitored. This study aimed to compare and analyze the differences of BP 
and BGL among elderly with HT and/or DM. This cross-sectional study 
involved 100 and 96 elderly with HT and/or DM in communities of Bangkok 
and Surabaya respectively (n=196). Instruments used were demography 
questionnaire, sphygmomanometer, and glucometer. Test of one-way 
ANOVA, LSD, Kruskal-Wallis, and Mann-Whitney U were used for data 
analysis (α<.05). There was a significant difference of systolic and diastolic 
BP found between groups (p=.000 and p=.011 respectively), but no 
difference found between the groups of HT and DM&HT (p=.657 and 
p=.330 respectively). There was a significant difference of BGL found 
between groups (p=.002), but no difference found between the groups of HT 
and DM (p=.075), and between the groups of DM and DM&HT (p=.066).  
BP is significantly different between groups of HT and DM, but BGL is 
similar. Risk of HT is very high in elderly with DM. Elderly with DM&HT 
has high BP and BGL similarly to those with single disease of HT or DM. 
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1. INTRODUCTION 
Aging process is a natural process happen to everyone and cannot be avoided; this process occur 
biologically and psychologically [1]. In the world, people who aged more than 60 years old was amounted to 
13.4% of the whole human population in 2013, and this percentage was estimated to be doubled up to 25.3% 
in 2050, in which 8% of these elderly people live in Asia [2]. 
Various changes in organ function and body system happen physiologically in elderly. Due to 
biological changes, elderly will face many problems physically, such as the occurence of chronic illness or 
well-known as NCD. NCD is not passed from person to person; it is long of duration and generally slow in 
progression. The four main types of NCD are cardiovascular disease (e.g. hypertension/HT), cancer,  
chronic respiratory disease, and diabetes mellitus (DM). 80% of all NCD deaths occur in  
low-and middle-income countries. Almost three quarters of NCD deaths (28 million) occur in  
low-and middle-income countries. 16 million NCD deaths occur before the age of 70, 82% of these 
"premature" deaths occurred in low-and middle-income countries [3]. 
In Indonesia, the amount of elderly people was around 24.9 million or 8.9% in 2013, and it was 
estimated to be increased up to 29.8 million or 21.4%. Among all the provinces in Indonesia, Province of 
Each Java, in which its capital is Surabaya, has sat in the 2nd rank in the country as the highest elderly 
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population with 10.4% of the population. The prevalence of HT in Indonesian elderly increase up to 50% in 
2014 [4]. Number of HT prevalence in 2016 as many as 10.43% in Surabaya only [5]. Morbidity rate of 
elderly in 2015 was 28.62%, meaning there were 28 sick elderly every 100 elderly population, in which HT 
was the highest NCD found in elderly [6]. Regarding DM, Indonesia is one of the top ten countries with 
highest DM prevalence. In 2000, people with DM amounted to 8,426,000, and WHO predicted that in 2030 
this number will increase up to 21,257,000. An epidemiological study conducted in Indonesia showed that 
DM prevalence was 1.5 up to 2.3% in people aged more than 15 years old, and DM prevalence was 14.7% 
and 7.2% in urban and rural area respectively [7]. 
Thailand started to be an elderly society since 2010 in which the number of elderly was 15.3% in 
2014. The prevalence of HT and hypercholesterolemia is high, but self-awareness is low, especially in urban 
area. Although some efforts have made to address NCD problems, but it is steadily rise each year. Among the 
top ten conditions in the disease burden ranking in Thailand, nine are NCDs. In 2009, HT and DM 
prevalence per-100,000 population were 981 and 736 respectively. Risk factors for NCD such as HT and DM 
have more than tripled over the last two decades. In 2011, diseases of circulatory system and diseases of 
endocrine, nutritional, and metabolic were being the two of the top ten leading causes of hospital deaths by 
68.8 and 13.8 per-100,000 population respectively [8]. 
The incidence of elderly with HT is caused by many factors that are closely related to the natural 
aging process. Some studies concluded that age is also one factor in the occurrence of HT because the 
increased age of a person will increase the risk of HT. Elevated BP in elderly happens due to the functional 
changes in the peripheral vessel system, which involves some process of atherosclerosis, reduced elasticity of 
connective tissue, a decreased relaxation of smooth muscle of blood vessels that decrease the ability of 
distention and tensile strength [9]. Complications will also occur in people with HT, such as coronary heart 
disease, heart failure, brain blood vessel damage, and kidney failure [10]. 
Category of BP based on the New ACC/AHA Blood Pressure Guidelines which consists of:  
a) Normal=less than 120/80 mmHg. b) Elevated=systolic between 120-129 mmHg and diastolic less than 80 
mmHg. c) Stage 1=systolic between 130-139 mmHg or diastolic between 80-89 mmHg. d) Stage 2=systolic 
at least 140 mmHg or diastolic at least 90 mmHg, and e) hypertensive crisis=systolic over 180 mmHg and/or 
diastolic over 120 mmHg [11]. HT begins from stage 1 in which systolic BP between 130-139 mmHg or 
diastolic BP between 80-89 mmHg. The incidence of elderly with DM, especially type 2, is caused by 
various factors. Generally, the age of more than 40 years old has higher potency to develop DM, added by  
a family history of DM [9]. DM risk increases together with the increase of age and body weight, especially 
obesity (found in 80-90% patients). In DM type 2 (80-90% of cases), the pancreas still produce enough 
insulin (sometimes more than normal), but the body develops resistance due to various factors related to 
unhealthy life style, such as lack of exercise and imbalance diet pattern [12-13]. 
Based on PERKENI consensus, normal value of BGL if measured by using capillary blood as 
speciment is less than 200 mg/dL (without fasting) [14]. Therefore, the category of BGL was  
hyperglycemia=≥200 mg/dL, euglycemia=71-199 mg/dL, and hypoglycemia=≤70 mg/dL. DM often 
associated with hyperglycemia in which BGL≥200 mg/dL. This study aimed to compare and analyze the 
differences of BP and BGL among elderly with HT and/or DM in Bangkok and Surabaya. Elderly with DM 
potentially develop HT during the disease progression. HT and/or DM share some similar potency of having 
disease complications, such as coronary heart disease, heart failure, brain blood vessel damage (stroke), 
kidney failure, etc. The result of this study may be beneficial for monitoring the physical condition of elderly 
with HT and/or DM in community context, as well as for early detection of disease complication,  
especially from DM becoming HT or DM&HT. 
 
 
2. RESEARCH METHOD 
This was a Cross-sectional study involving 196 elderly with DM and/or HT in communities in 
Surabaya and Bangkok. There were 96 and 100 cases compiled from Surabaya and Bangkok respectively.  
In Bangkok, there were five communities used as the study sites. In Surabaya, there were three communities 
used as study sites: RW V, VI, and VII in the district of Mojo. Sample distribution between two sites is 
presented in Table 1. 
 
 
Table 1. Sample distribution 
Case Bangkok Surabaya Total 
DM 30 30 60 
HT 35 33 68 
DM&HT 35 33 68 
Total 100 96 196 
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Sample was chosen by criteria then totally included in the study (total sampling). Inclusion criteria 
consist of: (a) Elderly who are willing to participate in the study. (b) Consume medication from medical 
doctor to treat the disease. Exclusion criteria were cannot communicate using Pasa Thai or Bahasa Indonesia. 
Sample then divided into three groups based on the cases, namely groups of DM, HT, and DM&HT. 
Variables were systolic and diastolic BP, and BGL which were measured by calibrated sphygmomanometer 
and glucometer. Demography questionnaire was made to collect the data of respondents’ characteristic.  
Test of one-way ANOVA, Least Significant Difference (LSD), Kruskal-Wallis, and Mann-Whitney U were 
used for data analysis (α<.05).  
In this study, there were some confounding variables identified which can interfere the level of BP 
and BGL in elderly with DM and/or HT, such as: age, diet, exercise, stress, sleep, drugs consumed, and  
co-morbidity. Age was conditioned in elderly population only to minimize the potential differences existed in 
various age groups. The factors of diet and exercise was not strictly conditioned because it was very hard to 
do so, therefore this become our study limitations. Prior to data collection, we assessed respondent’s stress 
level by using instrument of SPST-20, and we excluded respondents with severe stress level. We also 
excluded respondents with insomnia, heart disease, renal disease, and other serious co-morbidity. As for drug 
consumption, we only included respondents who follow regiments from medical doctor regularly.  
Ethical clearance was issued by Ethical Committee of Saint Louis College (SLC), Bangkok, Thailand 
(November, 2016), with certificate number: E.038/2559. There was no conflict of interest between authors 
and study funder regarding this study and publication. 
 
 
3. RESULTS AND DISCUSSION 
In total, the study respondents composed of 15.82% male and 84.18% female. Age range  
was 60–78 years old. The educational background of sample in Bangkok was mostly primary school (53%), 
while in Surabaya was mostly secondary school (64.58%). The income of sample in Bangkok was mostly 
43% at THB 2000-6000 per-month (43%), while in Surabaya was mostly less than IDR 800 thousand per 
month (53.13%). In Bangkok, most respondents has relative who suffered from DM/HT (66%), while in 
Surabaya no family background was reported (69.79%). Table 2 presents the demography  
characteristic of respondents. 
In total (n=196), mostly we found stage 2 of HT (44.39%) but Mean value of BP was higher in 
Bangkok. Mean value of BP in Surabaya is considered as stage 1 of HT. The data of systolic BP was more 
various in Surabaya, but the data of diastolic BP was more various in Bangkok (based on SD value).  
Table 3 presents the comparison of BP between two study sites. In total (n=196), mostly we found 
euglycemia condition (81.63%), and the Mean value of BGL was also considered as euglycemia in both sites. 
The data of BGL was more various in Bangkok (based on SD value). Table 4 presents the results of LSD test 
representing the comparison of BGL between two study sites. 
Based on the result of Kolmogorov-Smirnov test, we found that only the data of systolic BP which 
was normally distributed (p=.105), therefore the test of one-way ANOVA was used for analyzing the 
differences between three groups of samples. Results showed that there was a significant difference of 
systolic BP found between groups (p=.000). LSD test then was used for finding which groups determined 
this difference. It was showed that systolic BP was significantly different between the groups of HT and DM 
(p=.000) and between the groups of DM and DM&HT (p=.000), but no difference found between the groups 
of HT and DM&HT (p=.657). It means systolic BP was not much different between the elderly with single 
disease of HT and those who have more complicated NCD like DM&HT. As for the elderly with single 
disease of DM, it was expected to find their systolic BP was very different from the other groups because 
potentially no complications of elevated systolic BP existed at the moment.  
Based on the results of Kolmogorov-Smirnov test, we found that the data of diastolic BP was not 
normally distributed (p=.003), therefore the nonparametric test of Kruskal-Wallis was used for analyzing the 
differences between three groups of samples. Results showed that there was a significant difference of 
diastolic BP found between groups (p=.011). Mann-Whitney U test then was used for finding which groups 
determined this difference. It was showed that diastolic BP was significantly different between the groups of 
HT and DM (p=.004) and between the groups of DM and DM&HT (p=.033), but no difference found 
between the groups of HT and DM&HT (p=.330). It means diastolic BP was not much different between the 
elderly with single disease of HT and those who have more complicated NCD like DM&HT. As for the 
elderly with single disease of DM, it was expected to find their diastolic BP was very different from the other 
groups because potentially no complications of elevated diastolic BP existed at the moment. Table 5 presents 
the results of Mann-Whitney U test for diastolic BP in details. 
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Table 2. Demography characteristic 
Characteristic 
Bangkok (100) Surabaya (96) 
n % n % 
1. Sex 
a. Male 
b. Female 
 
20 
80 
 
20 
80 
 
11 
85 
 
11.45 
88.54 
2. Age (years old) 
a. 60-69 
b. >70 
 
48 
52 
 
48 
52 
 
75 
21 
 
78.13 
21.87 
3. Education 
a. Primary school 
b. Secondary school 
c. Bachelor degree 
d. No study 
 
53 
25 
8 
14 
 
53 
25 
8 
14 
 
25 
62 
9 
0 
 
26.04 
64.58 
9.38 
0 
4. Occupation 
a. Farmer 
b. Businessman 
c. Government officer 
d. Other (retire, housewife) 
 
1 
10 
2 
87 
 
1 
10 
2 
87 
 
0 
12 
1 
83 
 
0 
12.50 
1.04 
86.46 
5. Monthly income 
a. THB<2,000 (IDR<800,000) 
b. THB 2,000-6,000 (IDR 800,000-2.4 million) 
c. THB 6,000-10,000 (IDR 2.41-4 million) 
d. THB>10,000 (IDR>4 million) 
 
18 
43 
19 
20 
 
18 
43 
19 
20 
 
51 
31 
10 
4 
 
53.13 
32.29 
10.42 
4.17 
6. Family background of HT/DM 
a. Yes 
b. No 
 
66 
34 
 
66 
34 
 
29 
67 
 
30.21 
69.79 
 
 
Table 3. Comparison of BGL 
Category 
Bangkok (100) Surabaya (96) 
n % n % 
Hyperglycemia 12 12 21 21.88 
Euglycemia 86 86 74 77.08 
Hypoglycemia 2 2 1 1.04 
Mean 155.62 137.90 
SD 65.71 49.34 
 
 
Table 4. Results of LSD test 
Multiple Comparisons 
Dependent Variable: systolic BP 
LSD 
(I) group (J) group Mean Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
HT 
DM 17.86667* 3.45265 .000 11.0569 24.6764 
DM&HT 1.48529 3.34301 .657 -5.1082 8.0788 
DM 
HT -17.86667* 3.45265 .000 -24.6764 -11.0569 
DM&HT -16.38137* 3.45265 .000 -23.1911 -9.5716 
DM&HT 
HT -1.48529 3.34301 .657 -8.0788 5.1082 
DM 16.38137* 3.45265 .000 9.5716 23.1911 
*. The mean difference is significant at the 0.05 level. 
 
 
Table 5. Results of Mann-Whitney U test (diastolic BP) 
(I) group (J) group Mann-Whitney U Wilcoxon W Z 
Asymp. Sig. 
(2-tailed) 
HT DM 1447.000 3277.000 -2.861 .004* 
 DM&HT 2089.500 4435.500 -.973 .330 
DM HT 1447.000 3277.000 -2.861 .004* 
 DM&HT 1596.000 3426.000 -2.133 .033* 
DM&HT HT 2089.500 4435.500 -.973 .330 
 DM 1596.000 3426.000 -2.133 .033* 
*. The difference is significant at the 0.05 level. 
 
 
Based on the results of Kolmogorov-Smirnov test, we found that the data of BGL was not normally 
distributed (p=.000), therefore the nonparametric test of Kruskal-Wallis was used for analyzing the 
differences between three groups of samples. Results showed that there was a significant difference of BGL 
found between groups (p=.002). Mann-Whitney U test then was used for finding which groups determined 
this difference. It was showed that BGL was significantly different between the groups of HT and DM&HT 
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(p=.000), but no difference found between the groups of HT and DM (p=.075) and between the groups of 
DM and DM&HT (p=.066). It means BGL was not much different between the elderly with single disease of 
DM and those who have more complicated NCD like DM&HT. As for the elderly with single disease of HT, 
it was expected to find their BGL was very different from the other groups because potentially no metabolic 
disorder existed at the moment. Table 6 presents the results of Mann-Whitney U test for BGL in details. 
 
 
Table 6. Results of Mann-Whitney U test (BGL) 
(I) group (J) group Mann-Whitney U Wilcoxon W Z 
Asymp. Sig. 
(2-tailed) 
HT DM 1667.500 4013.500 -1.779 .075 
 DM&HT 1500.000 3846.000 -3.535 .000* 
DM HT 1667.500 4013.500 -1.779 .075 
 DM&HT 1655.000 3485.000 -1.839 .066 
DM&HT HT 1500.000 3846.000 -3.535 .000* 
 DM 1655.000 3485.000 -1.839 .066 
*. The difference is significant at the 0.05 level. 
 
 
In elderly who are living with HT and/or DM, physical parameter like BP and BGL could be good 
indicators for monitoring elderly’s health status. Results showed that there was a significant difference of 
systolic and diastolic BP found between groups (p=.000 and p=.011 respectively), but no difference found 
between the groups of HT and DM&HT (p=.657 and p=.330 respectively). There was a significant difference 
of BGL found between groups (p=.002), but no difference found between the groups of HT and DM (p=.075) 
and between the groups of DM and DM&HT (p=.066). 
This study finding indicate that whether the elderly has a single disease of HT or DM, in the end his 
BP and BGL are not significantly different with those who has more complicated disease like DM&HT.  
The more surprising fact is that we found the BGL between elderly with HT or DM was not significantly 
different. Theoretically, HT and DM are both the components of metabolic syndrome. DM could be resulted 
in HT as its complication during the disease progression, but not the opposite. This study results revealed that 
the risk of being HT for elderly with DM is extremely high. Once HT coexistent with DM, both BP and BGL 
are not significantly different with those who have a single disease only, and vice versa. 
This study finding were supported by a prospective diabetes study in United Kingdom (UK) towards 
1,148 patients which showed that HT was very common in people with type 2 DM; BP lowering could show 
dramatic benefits in reducing the risk of major macrovascular and microvascular complications [15].  
HT in DM cases is a prevalent risk factor and associated with increased risk for a number of DM 
complications, such as cardiovascular disease (CVD). HT increases the cardiovascular risk in diabetic 
patients by 2–3 fold [16]. This study results were also supported by a study of Chen, et al. (2011),  
towards 1,145 Framingham subjects who were newly diagnosed with DM [17]. They found that among all 
subjects who did not have a previous history of cardiovascular events, 58% had HT at the time of DM 
diagnosis, and much of this excess risk of DM is attributable to coexistent HT. Another supportive study was 
conducted towards 10,991 older adults aged≥60 years old which showed that the prevalence of the 
concomitant occurrence of HT and DM was 16.2%, with higher prevalence found in individuals living in 
capital cities, black or brown skin color, up to eight years of schooling, non-smokers, ex-smokers,  
and overweight [18].  
Long & Dagoo-Jack (2011) stated that up to 75% of adults with DM also have HT, and patients with 
HT alone often show evidence of insulin resistance [19]. Thus, HT and DM are common, which share  
a significant overlap in underlying risk factors (including ethnicity, familial, dyslipidemia, and lifestyle 
determinants) and complications of microvascular (including retinopathy, nephropathy, and neuropathy 
which linked to hyperglycemia) and macrovascular complications (including coronary artery disease, 
myocardial infarction, stroke, congestive heart failure, and peripheral vascular disease). HT constitutes  
an important risk factor, especially for nephropathy. The familial predisposition to DM and HT appears to be 
polygenic in origin. On the other hand, the shared lifestyle factors in the etiology of HT and DM provide 
ample opportunity for nonpharmacologic intervention. 
As a comparison to younger age groups, we analyzed a study of TODAY Study Group (2013) [20]. 
This cohort study was conducted towards 699 adolescents who had type 2 DM for less than two years. 
Primary study outcome was loss of glycemic control for six months or sustained metabolic decompensation 
requiring insulin. Results showed that 45.6% respondents reached primary study outcomes, and 11.6% were 
hypertensive at baseline and 33.8% by the end of study (average follow-up 3.9 years). It was concluded that 
male sex and higher BMI significantly increased the risk for HT in adolescent with type 2 DM. 
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A systematic literature review of Colosia, et al. (2013), towards 77 articles provided prevalence rates 
for HT and/or obesity specifically in adults with type 2 DM showed that 61studies reported HT prevalence, 
44 reported obesity prevalence, and 12 reported the prevalence of HT with obesity [21]. Most observational 
studies of HT or obesity prevalence were found in Europe and Asia, which revealed that HT and obesity rates 
were high in all regions. Among obese adults, HT rates were at or above 70% in Asia, 80% in Europe,  
and 30% in North and South America. HT and obesity, separately or together, are common comorbidities in 
adults with type 2 DM globally. Another study in Spain conducted by Ramon-Arbues (2019) towards 23,729 
workers (adults) in Aragon showed that prevalence of overweight and obesity was 38.6% and 18.4% 
respectively with higher prevalence found in males compared to females, and a significant association was 
found between overweight and obesity and prevalence of DM [22].  
Matsuda & Shimomura (2013) conducted a study to link obesity and increased oxidative stress [23]. 
Obesity, especially of the abdominal type, is a health problem that constitutes metabolic syndrome and 
increases the incidence of DM and HT. Oxidative stress has been postulated to be the linking mechanism of 
obesity and vascular complication-pancreatic β-cell failure of DM. The levels of oxidative stress present in 
several other types of cells or tissues have been implicated in the pathogenesis associated with HT.  
Another study of Pan, et al., toward 40 type 2 DM patients without complications, and 37 diabetic 
nephropathies, found that compared with 40 control subjects, superoxide dismutase, glutathione peroxidase, 
catalase, and vitamin C were decreased [24]. It was concluded that DM patients have more severe oxidative 
stress than normal persons and higher oxidative stress in diabetic nephropathy than those in DM patients 
without complications. Reactive oxygen species (ROS) may contribute to the development of  
obesity-associated insulin resistance and type 2 DM because ROS cause defective angiogenesis in response 
to ischemia, activate a number of proinflammatory pathways, and cause long-lasting epigenetic changes that 
drive persistent expression of proinflammatory genes after glycemia is normalized [25].  
Oxidative stress plays an important intermediary role in the pathogenesis of DM complications. 
There was a significant increase in serum malondialdehyde (MDA), Conjugated Diene (CD),  
Advanced Oxidation Protein Products (AOPP), Protein Carbonyl (PC) and 8-hydroxy-2′-deoxyguanosine  
(8-OHdG) in DM patients, especially individuals with diabetic nephropathy. Oxidative stress cause 
mitochondrial superoxide overproduction in endothelial cells of blood vessels and myocardium which 
resulted in an increase of superoxide production causes the activation of five major pathways:  
a) Polyol pathway flux. b) Increased formation of AGEs (Advanced Glycation End products).  
c) Increased expression of the receptor for AGEs and its activating ligands. d) Activation of protein kinase C 
isoforms, and e) Overactivity of the hexosamine pathway. It also directly inactivates two critical 
antiatherosclerotic enzymes, endothelial Nitric Oxide (NO) synthase and prostacyclin synthase. 
Atherosclerosis and cardiomyopathy in type 2 DM are caused in part by pathway-selective insulin resistance, 
which increases mitochondrial ROS production from free fatty acids and by inactivation of 
antiatherosclerosis enzymes by ROS [25]. 
Folli, et al. (2011), added some explanations to the above mentioned five pathways [26].  
The increased oxidative stress in subjects with type 2 DM is a consequence of several abnormalities, 
including hyperglycemia, insulin resistance, hyperinsulinemia, and dyslipidemia. The effects of oxidative 
stress in individuals with type 2 DM are compounded by the inactivation of two critical anti-atherosclerotic 
enzymes: endothelial nitric oxide synthase and prostacyclin synthase. The results of clinical trials in patients 
with type 2 DM with intensive management of all metabolic syndromes showed a decrease in adverse 
cardiovascular end points. 
The internationally accepted definition of HT in people with DM is now 130/80 mmHg and this 
level should be the target for all those on antihypertensive therapy [16]. A study towards 4,733 people with 
type 2 DM showed that in patients with type 2 DM who were at high risk for cardiovascular events, targeting 
a systolic BP of less than 120 mmHg, as compared with less than 140 mmHg, did not reduce the rate of  
a composite outcome of fatal and nonfatal major cardiovascular events [28]. Six years after, we found that 
the current treatment goal changes into<140/85–90 mmHg in most patients, but<130/80 mmHg in patients 
with macroalbuminuria as a sign of diabetic nephropathy [28]. 
Modern guidelines now recommend a structured program for the screening, diagnosis, and treatment 
of HT in DM. The current treatment goal is<140/85–90 mmHg in most patients, but<130/80 mmHg in 
patients with macroalbuminuria as a sign of diabetic nephropathy. Most antihypertensive drugs can be used 
to achieve this BP control, especially in combination treatment [28]. Most patients will require three or more 
drugs to achieve target BP; agents which block the renin angiotesin system, calcium channel blockers or 
diuretics are first line [16]. All respondents in this study have consumed antihypertensive drugs for some 
period of time, but their adherence to treatment was not closely monitored. Adherence differed little across 
elderly age groups. Adherence to antihypertensive drugs is not linked with reduced BP in patients with DM 
who are at least 85 years or with multiple comorbidities [29]. 
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Aside from the use of antihypertensive drugs to treat HT in DM patients, diet and lifestyle 
interventions can also have a significant impact on BP, and these should be recommended as the first line 
therapy [16]. As the evidence, results of a randomized crossover clinical trial towards 31 people with type 2 
DM in which they followed the eating/diet pattern of DASH (Dietary Approaches to Stop Hypertension) for 
eight weeks showed that in the end of study the fasting BGL, A1C, systolic and diastolic BP decreased 
significantly, as well as HDL and LDL cholesterol levels [30]. Another good lifestyle modification for DM 
patients is regular exercise. A study towards hypercholesterolemic patients who exercise regularly showed 
that the incidence of DM, HT, and cardiovascular disease decrease significantly [31].  
An interesting study towards 8,494 people with DM concluded that in relation to mortality or 
macrovascular events, BP monitoring/control was more important than intensive glycemic control. At first 
follow up, there was no difference of BP and glycated hemoglobin levels found between groups.  
But, at the end of follow up, the reductions in the risk of death from any cause and of death from 
cardiovascular causes were significant between groups. However, there was no difference found between  
the intensive-glucose-control group and the standard-glucose-control group regarding the risk of death from 
any cause or major macrovascular events [32]. A prospective study towards 1,918 consecutive patients with 
ACS diagnosis were followed up after 10 years showed that DM was the only clinical factor that aggravated 
ACS prognosis, whereas BP and dyslipidemia did not seem to determine the prognosis [33].  
In elderly with DM, we found the risk of HT complication was extremely high. Similar findings 
were also found in worldwide studies. HT was potentially coexistent with DM in the initial DM diagnosis. 
Both HT and DM are components of metabolic syndrome. The incidence of HT in people with DM was 
explained by various pathways. Management of people with DM should emphasize more in BP control, 
together with glycemic control. Dietary management and healthy life style should be the first line of 
antihypertensive therapy in people with DM, followed by antihypertensive drugs. BP and BGL controls in 
people with DM are important for reducing mortality and cardiovascular complications, both macro  
and microvascular. 
 
 
4. CONCLUSION 
Blood pressure is significantly different between the single disease group of HT and DM in term of 
systole and diastole, especially in elderly, but BGL is similar. The risk of being HT for elderly with DM is 
extremely high. Elderly with DM&HT have high BP and BGL similarly to those with single disease of HT or 
DM. This study finding indicate that whether the elderly has a single disease of HT or DM, in the end his BP 
and BGL are not significantly different with those who has more complicated disease like DM&HT.  
Once HT coexistent with DM, both BP and BGL are not significantly different with those who have a single 
disease only, and vice versa. 
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